CVRx to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call
October 21, 2021 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally...
BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial Ischemia
October 21, 2021 07:30 ET
|
BioCardia, Inc.
SAN CARLOS, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA] a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and...
Global Heart Hub and Novartis partner to tackle ASCVD, a global health crisis and world’s #1 killer
October 19, 2021 01:15 ET
|
Novartis Pharma AG
Invisible Nation is a worldwide network of patient organizations committed to driving a decline in cardiovascular (CV) death by effecting systemic change in atherosclerotic cardiovascular disease...
Dormie Network Helps Fight Congenital Heart Defects with Donation to Cameron Steinberg Foundation Annual Golf Fundraiser
October 11, 2021 09:00 ET
|
Dormie Network
Lincoln, Nebraska, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Dormie Network, a collection of private destination golf clubs, announced the Cameron Steinberg Foundation as the winner of the Play It Forward...
Lankenau Heart Institute, part of Main Line Health, first in North America to sign long-term strategic partnership with Philips utilizing integrated cardiovascular solutions
September 30, 2021 09:00 ET
|
Royal Philips
September 30, 2021 Unique five-year agreement will help Philadelphia-based health leader integrate and standardize innovative cardiovascular care, helping to deliver on the quadruple aim Amsterdam,...
CVRx Added to Russell 2000® and 3000® Indexes
September 17, 2021 08:00 ET
|
CVRx, Inc.
MINNEAPOLIS, Sept. 17, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and...
World-first agreement between Novartis and the NHS enables broad and rapid access to first-in-class cholesterol-lowering medicine Leqvio® ▼(inclisiran)
August 31, 2021 19:01 ET
|
Novartis Pharma AG
Agreement follows positive NICE recommendation and commits to deliver Leqvio® (inclisiran) access via a population health management approach identifying eligible patients across England1 Over three...
Global Critical Care Devices Market Predicted to Garner a Revenue of $41.5 Billion at a CAGR of 3.2% during the Forecast Period, 2019-2026 - Exclusive Report by Research Dive
August 30, 2021 09:07 ET
|
Research Dive
New York, USA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global critical care devices market is forecasted to reach $41.5 billion by the end of 2026,...
Philips spotlights smart diagnostic and treatment solutions driving clinical confidence and workflow efficiency at ESC 2021
August 26, 2021 04:00 ET
|
Royal Philips
August 26, 2021 Company’s innovative, integrated imaging systems, devices, software, informatics and services support greater efficiency, enabling high-quality care for a growing volume of complex...
CVRx Reports Second Quarter 2021 Financial and Operating Results
August 04, 2021 16:05 ET
|
CVRx, Inc.
MINNEAPOLIS, Aug. 04, 2021 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and...